# Taiyu Investment

> Taiyu Investment is a VC fund backing Medical, Health Care and Biotechnology. See 44 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 44
- Last investment: May 2026
- Lead investor: 20%
- Last updated: Aug 2026

Taiyu Investment is an investment firm.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $4.1M–$20M |
| Series A | $13M–$29M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 11 | 25% |
| Health Care | 6 | 14% |
| Biotechnology | 6 | 14% |
| Medical Device | 5 | 11% |
| Manufacturing | 4 | 9% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 8 | 18% |
| Series A | 7 | 16% |
| Angel | 3 | 7% |
| Series B | 1 | 2% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Immunocan | Immunocan focuses on the development of fully human antibody animals, artificial chromosome carriers with independent intellectual property rights, focusing on tumor treatment, and developing antibody therapeutic drugs. | $36.8M | Series A | May 13, 2026 |  |
| Rhino Medical | Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments | $14.5M | Series B | Mar 27, 2026 |  |
| Infineon Multiomics | Infineon Multiomics is a biotechnology company that provides research and application of space multiomics technology. | $7.4M | Seed | Mar 24, 2026 |  |
| Juhai Hengchuang | Juhai Hengchuang is a medical device manufacturer that exclusively sells and manufactures drug testing equipment. |  | Seed | Mar 18, 2026 |  |
| QL Biopharma | QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases. | $72.8M | Series C | Mar 02, 2026 |  |
| Greenon Biotech | Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on. | $14.2M | Series B | Dec 22, 2025 |  |
| Micro Interventional | Micro Interventional is a company that develops active interventional innovative medical devices. It emphasizes the development of novel medical devices with a product strategy centered on the precise interventional treatment of coronary heart disease and peripheral arterial disease. |  | Series A | Dec 16, 2025 |  |
| BV Laser | BV Laser is a manufacturer of medical beauty equipment. | $14.2M | Series C | Dec 15, 2025 |  |
| Best-Link Bioscience | Best-Link Bioscience is a high-tech enterprise engaged in innovative drug research and development, focusing on cutting-edge scientific discovery, advanced therapeutic technologies, and the creation of novel medicines to address unmet clinical needs and improve patient outcomes worldwide. | $36.7M | Series B | Dec 11, 2025 |  |
| Jirui Technology | Jirui Technology is a biopharmaceutical focused on developing automated systems for synthesizing molecular imaging tracer drugs. These tracer drugs are essential for nuclear medicine applications, enabling precise imaging for medical diagnoses. The company aims to improve diagnostic capabilities by providing efficient, reliable systems for thepreparation of radiopharmaceuticals. |  | Venture - Series Unknown | Apr 02, 2025 |  |

10 of 44 investments shown.

## Co-investors
- [Taiyu Investment](https://shizune.co/investors/profile/tigeryeah-capital) — VC Fund, 12 deals together
- [Tailong Investment](https://shizune.co/investors/profile/tailong-investment) — VC Fund, 4 deals together
- [Kingray Capital](https://shizune.co/investors/profile/kingray-capital) — VC Fund, 3 deals together
- [Med-Fine Capital](https://shizune.co/investors/profile/med-fine-capital) — VC Fund, 3 deals together
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 3 deals together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Health Care Investors in China](https://shizune.co/investors/health-care-investors-china)
- [Health Care VC Funds in China](https://shizune.co/investors/health-care-vc-funds-china)
- [Health Care Investors in Asia](https://shizune.co/investors/health-care-investors-asia)
- [Health Care VC Funds in Asia](https://shizune.co/investors/health-care-vc-funds-asia)
- [Medical VC Funds in Asia](https://shizune.co/investors/medical-vc-funds-asia)
- [Medical Investors in Asia](https://shizune.co/investors/medical-investors-asia)

## FAQ

### What does Taiyu Investment invest in?

Taiyu Investment invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 44 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Taiyu Investment's check size?

Taiyu Investment typically joins rounds of $4.1M–$20M at Seed and $13M–$29M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Taiyu Investment participates in.

### When did Taiyu Investment last invest?

The most recent investment recorded for Taiyu Investment closed in May 2026. Shizune tracks 44 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co